Although the sample size of patients with coronary artery disease was rather modest and additional studies with larger numbers of subjects or in vivo experiments are required to confirm the findings, our results suggest the novel and comprehensive roles of FABP4 in the pathogenesis of atherosclerosis from basic to clinical. Here, FABP4 is linked to coronary artery disorder.